Helen C. Adams, Director at Immix Biopharma, Inc. (IMMX), bought 13,000 shares at $2.96 ($38K) on 2023-09-12, disclosed to the SEC on 2023-09-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.